Sonnet BioTherapeutics (SONN) Earnings (2010 - 2025)
Sonnet BioTherapeutics (SONN) earnings from Jun 30, 2010 to Sep 30, 2025. The TTM Sonnet BioTherapeutics (SONN) earnings is -$16M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Sonnet BioTherapeutics (SONN) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +115.19% |
| 3 Years TTM | -18.64% |
| 5 Years TTM | -7.98% |
| 10 Years TTM | +1.21% |
| All Time TTM | +38.77% |
Annual Earnings change of Sonnet BioTherapeutics (SONN)
| Year | Earnings | Change |
|---|---|---|
| 2025 | -$16M | +115.19% |
| 2024 | -$7.44M | -60.49% |
| 2023 | -$19M | -36.64% |
| 2022 | -$30M | +18.98% |
| 2021 | -$25M | +2.93% |
| 2020 | -$24M | +36.89% |
| 2019 | -$18M | +158.83% |
| 2018 | -$6.85M | +0.88% |
| 2017 | -$6.79M | -25.22% |
| 2016 | -$9.08M | -25.21% |
| 2015 | -$12M | +89.69% |
| 2014 | -$6.40M | +22.84% |
| 2013 | -$5.21M | +64.35% |
| 2012 | -$3.17M | +173.28% |
| 2011 | -$1.16M | +14.85% |
| 2010 | -$1.01M | N/A |
Comparison Sonnet BioTherapeutics (SONN) five years earnings CAGR with competitors
Sonnet BioTherapeutics (SONN) five years earnings CAGR is -7.98%.